Article
Hydroxychloroquine as Prophylactic Adjunct to BCG Vaccination in High-Risk Neonates: A Hypothesis for Triple Efficacy in Tuberculosis Prevention, BCG-Complication Mitigation, and SCID Safety
2026-03-18
Abstract excerpt
<h4>Background: </h4> BCG vaccination at birth remains the cornerstone of neonatal tuberculosis (TB) protection in high-burden countries. However, BCG induces severe, potentially fatal disseminated infection (BCGosis) in infants with Severe Combined Immunodeficiency (SCID). Saudi Arabia's 2019 policy delay of BCG to six months of age—intended to reduce BCGitis in SCID—leaves the vast immunocompetent neonatal popul...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 57cab872-362f-5133-aa45-56a622fc49b1
- DOI
- 10.20944/preprints202603.1422.v1
